Skip to content
NOWCAST 비바카지노 Viva News at Noon
Watch on Demand
코인카지노

Pfizer, BioNTech seek emergency use of COVID-19 shots in US

Pfizer, BioNTech seek emergency use of COVID-19 shots in US
ahead of the holiday long lines for co vid testing. As the rate of new coronavirus cases keeps climbing, this is faster. It's broader, and what worries me it could be longer. As the pandemic rages on, experts warn of brutal weeks ahead, urging Americans to slow the virus is spread by not traveling this Thanksgiving instead to celebrate responsibly. I'm making the personal sacrifices not to infect my parents and my pregnant daughter, and there's a lot of people out there who know how to protect one another, and we just need to make sure we're all doing that. In addition to the surgeon coronavirus cases, the death toll is also climbing. More than 2000 people in the U. S died Thursday, according to data from Johns Hopkins University, the highest number since early May. Yes, were front line here in the hospital, but the real front line is on the streets in the grocery stores. Wash your hands where your Matt stay away. Meanwhile, the much anticipated Covic vaccines could be available to some as early as late December. Vaccines are close by their coming, you know, I said, help is on the way, which to me I think should motivate people, even Mawr, to double down. Because pretty soon we're gonna get a heck of a lot of help from a very efficacious vaccine. Two vaccines. I'm Mandy Gaither reporting.
코인카지노
Pfizer, BioNTech seek emergency use of COVID-19 shots in US
Pfizer formally asked U.S. regulators Friday to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic 맥스카지노 but not until after a long, hard winter.The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.The companies said that protection plus a good safety record means the vaccine should qualify for emergency use authorization, something the Food and Drug Administration can grant before the final testing is fully complete. In addition to the FDA submission, they have already started 맥스카지노rolling맥스카지노 applications in Europe and the U.K. and intend to submit similar information soon.With the coronavirus surging around the U.S. and the world, the pressure is on for regulators to make a speedy decision.맥스카지노Help is on the way,맥스카지노 Dr. Anthony Fauci, the top U.S. infectious disease expert said on the eve of Pfizer's announcement, adding that it's too early to abandon masks and other protective measures. 맥스카지노We need to actually double down on the public health measures as we're waiting for that help to come.맥스카지노Friday맥스카지노s filing sets off a chain of events as the FDA and its independent advisers debate if the shots are ready. If so, still another government group will have to decide how the initial limited supplies are rationed out to anxiously awaiting Americans.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 much vaccine is available and when is a moving target, but initial supplies will be scarce and rationed. Globally, Pfizer has estimated it could have 50 million doses available by year's end.About 25 million may become available for U.S. use in December, 30 million in January and 35 million more in February and March, according to information presented to the National Academy of Medicine this week. Recipients will need two doses, three weeks apart. The U.S. government has a contract to buy millions of Pfizer-BioNTech doses, as well as other candidates that pan out, and has promised shots will be free.Not far behind is competitor Moderna Inc.맥스카지노s COVID-19 vaccine. Its early data suggests the shots are as strong as Pfizer맥스카지노s, and that company expects to also seek emergency authorization within weeks.Here맥스카지노s what happens next:MAKING THE DATA PUBLICThe public맥스카지노s first chance to see how strong the evidence really is will come in early December at a public meeting of the FDA맥스카지노s scientific advisers.So far, what's known is based only on statements from Pfizer and BioNTech. Of 170 infections detected to date, only eight were among people who'd received the actual vaccine and the rest had gotten a dummy shot. On the safety side, the companies cite results from 38,000 study participants who've been tracked for two months after their second dose. That's a milestone FDA set because historically, vaccine side effects don't crop up later than that.맥스카지노We맥스카지노ll drill down on these data,맥스카지노 said FDA adviser Dr. Paul Offit of the Children맥스카지노s Hospital of Philadelphia.Think of it like science on trial. A few days before the meeting, the FDA will release its own internal analysis. That sets the stage for the advisers맥스카지노 daylong debate about any signs of safety concerns and how the new vaccine technology works before rendering a verdict.They맥스카지노ll recommend not just whether FDA should allow broader use of the vaccine generally but if so, for whom. For example, is there enough proof the vaccine works as well for older, sicker adults as for younger, healthier people?There맥스카지노s still no guarantee. 맥스카지노We don맥스카지노t know what that vote맥스카지노s going to be,맥스카지노 said former FDA vaccine chief Norman Baylor.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EMERGENCY USE ISN맥스카지노T THE SAME AS FULL APPROVALIf there's an emergency green light, 맥스카지노that vaccine is still deemed investigational. It맥스카지노s not approved yet,맥스카지노 Dr. Marion Gruber, chief of FDA맥스카지노s vaccine office, told the National Academy of Medicine this week.That means anyone offered an emergency vaccination must get a 맥스카지노fact sheet맥스카지노 describing potential benefits and risks before going through with the shot, she said.There will be a lot of unknowns. For example, the 95% protection rate is based on people who developed symptoms and then were tested for the virus. Can the vaccinated get infected but have no symptoms, able to spread the virus? How long does protection last? That맥스카지노s why the 44,000-person study needs to keep running 맥스카지노 something difficult considering ethically, participants given dummy shots at some point must be offered a real vaccine, complicating the search for answers.맥스카지노I'm curious," said Barry Colvin, 52, of White Plains, New York, who is taking part in that study at NYU Langone Health.But he's not in a great hurry to find out which group he's in. 맥스카지노You need to hang in there for a while to understand and answer a lot of the other questions that remain unknown.맥스카지노Additionally at least for now, pregnant women won't qualify because they weren't studied. Pfizer only recently began testing the vaccine in children as young as 12.A decision on Pfizer-BioNTech's vaccine won't affect other COVID-19 vaccine candidates in the pipeline, which will be judged separately.MANUFACTURINGBrewing a vaccine is more complex than typical drug manufacturing, yet the millionth dose to roll out of Pfizer맥스카지노s Kalamazoo, Michigan, factory must be the same purity and potency as every dose before and after.That means the FDA decision isn맥스카지노t just based on study data, but on its determination that the vaccine is being made correctly.The Pfizer-BioNTech vaccine 맥스카지노 and Moderna's shots 맥스카지노 are made with brand-new technology. They don맥스카지노t contain the actual coronavirus. Instead, they맥스카지노re made with a piece of genetic code for the 맥스카지노spike맥스카지노 protein that studs the virus.That messenger RNA, or mRNA, instructs the body to make some harmless spike protein, training immune cells to recognize it if the real virus eventually comes along.GETTING INTO PEOPLE맥스카지노S ARMSAnother government group 맥스카지노 advisers to the Centers for Disease Control and Prevention 맥스카지노 decides who is first in line for scarce doses. Health and Human Services Secretary Alex Azar said he hopes that decision can be made at the same time as FDA맥스카지노s.The Trump administration맥스카지노s Operation Warp Speed has worked with states to line up how many doses they맥스카지노d need to cover the populations offered vaccine first.Pfizer will ship those supplies as ordered by the states 맥스카지노 only after FDA gives the OK.Company projections of how much it will ship each month are just predictions, Baylor warned.맥스카지노It맥스카지노s not like a pizza,맥스카지노 he said. Manufacturing is so complex that 맥스카지노you don맥스카지노t necessarily end up with what you thought.맥스카지노___AP video journalist Kathy Young contributed to this report.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute맥스카지노s Department of Science Education. The AP is solely responsible for all content.

Pfizer formally asked U.S. regulators Friday to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic 맥스카지노 but not until after a long, hard winter.

The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

코인카지노

The companies said that protection plus a good safety record means the vaccine should qualify for emergency use authorization, something the Food and Drug Administration can grant before the final testing is fully complete. In addition to the FDA submission, they have already started 맥스카지노rolling맥스카지노 applications in Europe and the U.K. and intend to submit similar information soon.

With the coronavirus surging around the U.S. and the world, the pressure is on for regulators to make a speedy decision.

[related id='7acffdad-c4b4-4691-a908-b414858a4cd8' align='center'][/related]

맥스카지노Help is on the way,맥스카지노 Dr. Anthony Fauci, the top U.S. infectious disease expert said on the eve of Pfizer's announcement, adding that it's too early to abandon masks and other protective measures. 맥스카지노We need to actually double down on the public health measures as we're waiting for that help to come.맥스카지노

Friday맥스카지노s filing sets off a chain of events as the FDA and its independent advisers debate if the shots are ready. If so, still another government group will have to decide how the initial limited supplies are rationed out to anxiously awaiting Americans.


[related id='b9b3f239-6c58-4dd4-9e2f-4156de8ab135' align='center'][/related]

How much vaccine is available and when is a moving target, but initial supplies will be scarce and rationed. Globally, Pfizer has estimated it could have 50 million doses available by year's end.

About 25 million may become available for U.S. use in December, 30 million in January and 35 million more in February and March, according to information presented to the National Academy of Medicine this week. Recipients will need two doses, three weeks apart. The U.S. government has a contract to buy millions of Pfizer-BioNTech doses, as well as other candidates that pan out, and has promised shots will be free.

Not far behind is competitor Moderna Inc.맥스카지노s COVID-19 vaccine. Its early data suggests the shots are as strong as Pfizer맥스카지노s, and that company expects to also seek emergency authorization within weeks.

[related id='89fb5206-006d-45ba-84d6-04f4006e81b0' align='center'][/related]

Here맥스카지노s what happens next:

MAKING THE DATA PUBLIC

The public맥스카지노s first chance to see how strong the evidence really is will come in early December at a public meeting of the FDA맥스카지노s scientific advisers.

So far, what's known is based only on statements from Pfizer and BioNTech. Of 170 infections detected to date, only eight were among people who'd received the actual vaccine and the rest had gotten a dummy shot. On the safety side, the companies cite results from 38,000 study participants who've been tracked for two months after their second dose. That's a milestone FDA set because historically, vaccine side effects don't crop up later than that.

맥스카지노We맥스카지노ll drill down on these data,맥스카지노 said FDA adviser Dr. Paul Offit of the Children맥스카지노s Hospital of Philadelphia.

Think of it like science on trial. A few days before the meeting, the FDA will release its own internal analysis. That sets the stage for the advisers맥스카지노 daylong debate about any signs of safety concerns and how the new vaccine technology works before rendering a verdict.

They맥스카지노ll recommend not just whether FDA should allow broader use of the vaccine generally but if so, for whom. For example, is there enough proof the vaccine works as well for older, sicker adults as for younger, healthier people?

There맥스카지노s still no guarantee. 맥스카지노We don맥스카지노t know what that vote맥스카지노s going to be,맥스카지노 said former FDA vaccine chief Norman Baylor.

[related id='aacc59d0-7515-4750-b84d-fd01b24459dc' align='center'][/related]

EMERGENCY USE ISN맥스카지노T THE SAME AS FULL APPROVAL

If there's an emergency green light, 맥스카지노that vaccine is still deemed investigational. It맥스카지노s not approved yet,맥스카지노 Dr. Marion Gruber, chief of FDA맥스카지노s vaccine office, told the National Academy of Medicine this week.

That means anyone offered an emergency vaccination must get a 맥스카지노fact sheet맥스카지노 describing potential benefits and risks before going through with the shot, she said.

There will be a lot of unknowns. For example, the 95% protection rate is based on people who developed symptoms and then were tested for the virus. Can the vaccinated get infected but have no symptoms, able to spread the virus? How long does protection last?

That맥스카지노s why the 44,000-person study needs to keep running 맥스카지노 something difficult considering ethically, participants given dummy shots at some point must be offered a real vaccine, complicating the search for answers.

맥스카지노I'm curious," said Barry Colvin, 52, of White Plains, New York, who is taking part in that study at NYU Langone Health.

But he's not in a great hurry to find out which group he's in. 맥스카지노You need to hang in there for a while to understand and answer a lot of the other questions that remain unknown.맥스카지노

Additionally at least for now, pregnant women won't qualify because they weren't studied. Pfizer only recently began testing the vaccine in children as young as 12.

A decision on Pfizer-BioNTech's vaccine won't affect other COVID-19 vaccine candidates in the pipeline, which will be judged separately.

MANUFACTURING

Brewing a vaccine is more complex than typical drug manufacturing, yet the millionth dose to roll out of Pfizer맥스카지노s Kalamazoo, Michigan, factory must be the same purity and potency as every dose before and after.

That means the FDA decision isn맥스카지노t just based on study data, but on its determination that the vaccine is being made correctly.

The Pfizer-BioNTech vaccine 맥스카지노 and Moderna's shots 맥스카지노 are made with brand-new technology. They don맥스카지노t contain the actual coronavirus. Instead, they맥스카지노re made with a piece of genetic code for the 맥스카지노spike맥스카지노 protein that studs the virus.

That messenger RNA, or mRNA, instructs the body to make some harmless spike protein, training immune cells to recognize it if the real virus eventually comes along.

GETTING INTO PEOPLE맥스카지노S ARMS

Another government group 맥스카지노 advisers to the Centers for Disease Control and Prevention 맥스카지노 decides who is first in line for scarce doses. Health and Human Services Secretary Alex Azar said he hopes that decision can be made at the same time as FDA맥스카지노s.

The Trump administration맥스카지노s Operation Warp Speed has worked with states to line up how many doses they맥스카지노d need to cover the populations offered vaccine first.

Pfizer will ship those supplies as ordered by the states 맥스카지노 only after FDA gives the OK.

Company projections of how much it will ship each month are just predictions, Baylor warned.

맥스카지노It맥스카지노s not like a pizza,맥스카지노 he said. Manufacturing is so complex that 맥스카지노you don맥스카지노t necessarily end up with what you thought.맥스카지노

___

AP video journalist Kathy Young contributed to this report.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute맥스카지노s Department of Science Education. The AP is solely responsible for all content.